280 related articles for article (PubMed ID: 35849939)
1. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
Kang KM; Lee I; Nam H; Kim YC
Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel PARP-1 inhibitors using tandem
Bhatnagar A; Nath V; Kumar N; Kumar V
J Biomol Struct Dyn; 2024 Apr; 42(7):3396-3409. PubMed ID: 37216358
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 5-methyl-1H-benzo[d]imidazole derivatives as novel P2X3 Receptor antagonists.
Bae J; Kang KM; Kim YC
Bioorg Med Chem Lett; 2022 Sep; 72():128820. PubMed ID: 35644300
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
6. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
[TBL] [Abstract][Full Text] [Related]
7. Discovery of high affinity ligands for β2-adrenergic receptor through pharmacophore-based high-throughput virtual screening and docking.
Yakar R; Akten ED
J Mol Graph Model; 2014 Sep; 53():148-160. PubMed ID: 25137647
[TBL] [Abstract][Full Text] [Related]
8. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Structure-Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents.
Bae J; Kim YO; Han X; Yoon MH; Kim WM; Kim YC
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209126
[TBL] [Abstract][Full Text] [Related]
10. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
Ahmadi M; Nowroozi A; Shahlaei M
J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
[TBL] [Abstract][Full Text] [Related]
11. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives.
Tobinaga H; Kameyama T; Asahi K; Horiguchi T; Oohara M; Taoda Y; Hata K; Hasegawa T; Tada Y; Kurihara N; Kanda Y; Yagi S; Tomari M; Tanaka Y; Takahashi F; Taniguchi E; Takahara Y; Shimada S; Takeyama C; Yamamoto S; Shinohara S; Kai H
Bioorg Med Chem Lett; 2020 Dec; 30(24):127636. PubMed ID: 33132115
[TBL] [Abstract][Full Text] [Related]
13. Multi-Dimensional Screening Strategy for Drug Repurposing with Statistical Framework-A New Road to Influenza Drug discovery.
Rohini K; Ramanathan K; Shanthi V
Cell Biochem Biophys; 2019 Dec; 77(4):319-333. PubMed ID: 31559538
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
[TBL] [Abstract][Full Text] [Related]
15. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles.
Lans I; Palacio-Rodríguez K; Cavasotto CN; Cossio P
J Comput Aided Mol Des; 2020 Oct; 34(10):1063-1077. PubMed ID: 32656619
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy.
Wang M; Hou S; Liu Y; Li D; Lin J
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771087
[TBL] [Abstract][Full Text] [Related]
17. Refined pharmacophore features for virtual screening of human thromboxane A2 receptor antagonists.
Hu B; Joseph J; Geng X; Wu Y; Suleiman MR; Liu X; Shi J; Wang X; He Z; Wang J; Cheng M
Comput Biol Chem; 2020 Jun; 86():107249. PubMed ID: 32199335
[TBL] [Abstract][Full Text] [Related]
18. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
Kumar R; Jade D; Gupta D
J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
[TBL] [Abstract][Full Text] [Related]
19. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
Zaka M; Abbasi BH; Durdagi S
J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
[TBL] [Abstract][Full Text] [Related]
20. Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening.
Guzelj S; Tomašič T; Jakopin Ž
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
